BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 16135682)

  • 1. Anti-endothelial cell antibodies in idiopathic and systemic sclerosis associated pulmonary arterial hypertension.
    Tamby MC; Chanseaud Y; Humbert M; Fermanian J; Guilpain P; Garcia-de-la-Peña-Lefebvre P; Brunet S; Servettaz A; Weill B; Simonneau G; Guillevin L; Boissier MC; Mouthon L
    Thorax; 2005 Sep; 60(9):765-72. PubMed ID: 16135682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to fibroblasts in idiopathic and scleroderma-associated pulmonary hypertension.
    Tamby MC; Humbert M; Guilpain P; Servettaz A; Dupin N; Christner JJ; Simonneau G; Fermanian J; Weill B; Guillevin L; Mouthon L
    Eur Respir J; 2006 Oct; 28(4):799-807. PubMed ID: 16774952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-endothelial cell antibodies from patients with limited cutaneous systemic sclerosis bind to centromeric protein B (CENP-B).
    Servettaz A; Tamby MC; Guilpain P; Reinbolt J; Garcia de la Penã-Lefebvre P; Allanore Y; Kahan A; Meyer O; Guillevin L; Mouthon L
    Clin Immunol; 2006 Aug; 120(2):212-9. PubMed ID: 16580263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgG reactivity with a 100-kDa tissue and endothelial cell antigen identified as topoisomerase 1 distinguishes between limited and diffuse systemic sclerosis patients.
    García de la Peña-Lefebvre P; Chanseaud Y; Tamby MC; Reinbolt J; Batteux F; Allanore Y; Kahan A; Meyer O; Benveniste O; Boyer O; Guillevin L; Boissier MC; Mouthon L
    Clin Immunol; 2004 Jun; 111(3):241-51. PubMed ID: 15183145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of target antigens of antifibroblast antibodies in pulmonary arterial hypertension.
    Terrier B; Tamby MC; Camoin L; Guilpain P; Broussard C; Bussone G; Yaïci A; Hotellier F; Simonneau G; Guillevin L; Humbert M; Mouthon L
    Am J Respir Crit Care Med; 2008 May; 177(10):1128-34. PubMed ID: 18276943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targets of anti-endothelial cell antibodies in pulmonary hypertension and scleroderma.
    Dib H; Tamby MC; Bussone G; Regent A; Berezné A; Lafine C; Broussard C; Simonneau G; Guillevin L; Witko-Sarsat V; Humbert M; Mouthon L
    Eur Respir J; 2012 Jun; 39(6):1405-14. PubMed ID: 22005913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nailfold capillary density is associated with the presence and severity of pulmonary arterial hypertension in systemic sclerosis.
    Hofstee HM; Vonk Noordegraaf A; Voskuyl AE; Dijkmans BA; Postmus PE; Smulders YM; Serné EH
    Ann Rheum Dis; 2009 Feb; 68(2):191-5. PubMed ID: 18375538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis.
    Hénault J; Tremblay M; Clément I; Raymond Y; Senécal JL
    Arthritis Rheum; 2004 Oct; 50(10):3265-74. PubMed ID: 15476238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgG from patients with pulmonary arterial hypertension and/or systemic sclerosis binds to vascular smooth muscle cells and induces cell contraction.
    Bussone G; Tamby MC; Calzas C; Kherbeck N; Sahbatou Y; Sanson C; Ghazal K; Dib H; Weksler BB; Broussard C; Verrecchia F; Yaici A; Witko-Sarsat V; Simonneau G; Guillevin L; Humbert M; Mouthon L
    Ann Rheum Dis; 2012 Apr; 71(4):596-605. PubMed ID: 22084393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifibroblast antibodies from systemic sclerosis patients bind to {alpha}-enolase and are associated with interstitial lung disease.
    Terrier B; Tamby MC; Camoin L; Guilpain P; Bérezné A; Tamas N; Broussard C; Hotellier F; Humbert M; Simonneau G; Guillevin L; Mouthon L
    Ann Rheum Dis; 2010 Feb; 69(2):428-33. PubMed ID: 19293162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-agalactosyl IgG antibodies in sera from patients with systemic sclerosis.
    Nishijima C; Sato S; Takehara K
    J Rheumatol; 2001 Aug; 28(8):1847-51. PubMed ID: 11508588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
    Hamaguchi Y
    J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-DNA topoisomerase II alpha autoantibodies in Japanese patients with systemic sclerosis.
    Hayakawa I; Hasegawa M; Takehara K; Sato S
    Arch Dermatol Res; 2005 Oct; 297(4):180-3. PubMed ID: 16180014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiendothelial cell antibodies in scleroderma correlate with severe digital ischemia and pulmonary arterial hypertension.
    Negi VS; Tripathy NK; Misra R; Nityanand S
    J Rheumatol; 1998 Mar; 25(3):462-6. PubMed ID: 9517764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral arterial stiffness and endothelial dysfunction in idiopathic and scleroderma associated pulmonary arterial hypertension.
    Peled N; Shitrit D; Fox BD; Shlomi D; Amital A; Bendayan D; Kramer MR
    J Rheumatol; 2009 May; 36(5):970-5. PubMed ID: 19369472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosis.
    Becker MO; Kill A; Kutsche M; Guenther J; Rose A; Tabeling C; Witzenrath M; Kühl AA; Heidecke H; Ghofrani HA; Tiede H; Schermuly RT; Nickel N; Hoeper MM; Lukitsch I; Gollasch M; Kuebler WM; Bock S; Burmester GR; Dragun D; Riemekasten G
    Am J Respir Crit Care Med; 2014 Oct; 190(7):808-17. PubMed ID: 25181620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-lipoprotein lipase antibody in systemic sclerosis: association with elevated serum triglyceride concentrations.
    Kodera M; Hayakawa I; Komura K; Yanaba K; Hasegawa M; Takehara K; Sato S
    J Rheumatol; 2005 Apr; 32(4):629-36. PubMed ID: 15801017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-p53 autoantibody in systemic sclerosis: association with limited cutaneous systemic sclerosis.
    Hara T; Ogawa F; Muroi E; Komura K; Takenaka M; Hasegawa M; Fujimoto M; Sato S
    J Rheumatol; 2008 Mar; 35(3):451-7. PubMed ID: 18203319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies against calpastatin in sera from patients with systemic sclerosis.
    Sato S; Hasegawa M; Nagaoka T; Takamatsu Y; Yazawa N; Ihn H; Kikuchi K; Takehara K
    J Rheumatol; 1998 Nov; 25(11):2135-9. PubMed ID: 9818655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis.
    Chizzolini C; Raschi E; Rezzonico R; Testoni C; Mallone R; Gabrielli A; Facchini A; Del Papa N; Borghi MO; Dayer JM; Meroni PL
    Arthritis Rheum; 2002 Jun; 46(6):1602-13. PubMed ID: 12115192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.